Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 2001, p. 4483-4486, Vol. 39, No. 12
National Institute of Public Health and the
Environment, Bilthoven, The Netherlands
Received 19 June 2001/Returned for modification 23 July
2001/Accepted 17 September 2001
A duplex PCR assay targeting the ail and 16S rRNA
genes of Yersinia enterocolitica was developed to
specifically identify pathogenic Y. enterocolitica from
pure culture. Validation of the assay was performed with 215 clinical
Yersinia strains and 40 strains of other bacterial
species. Within an assay time of 4 h, this assay offers a very
specific, reliable, and inexpensive alternative to the conventional
phenotypic assays used in clinical laboratories to identify pathogenic
Y. enterocolitica.
Yersinia
enterocolitica is an important human enteroinvasive pathogen
with a global distribution (3, 5, 22). Worldwide surveillance data show an extensive increase in the number of non-outbreak-related isolates and cases of yersiniosis reported in the
last two decades. This notice has led to the referral of Y. enterocolitica as a potential emerging enteric human pathogen worldwide (17, 22, 28).
In contrast to most other common bacterial enteropathogens, Y. enterocolitica is able to proliferate at temperatures of about 4°C. This psychrophilic nature is responsible for the survival of the bacterium at temperatures found in refrigerators, e.g., in food
(1, 2, 5, 6) or packed red blood cells needed for
transfusion (7, 14, 30). Pigs are regarded as a major reservoir of Y. enterocolitica, and in particular, the
consumption of porcine tongue and tonsils is considered a risk factor
(1, 5, 6). The clinical spectrum of Y. enterocolitica infections varies with age and underlying
conditions (3). Most commonly, yersiniosis is associated
with gastroenteritis, although in children more severe clinical
manifestations (peritonitis, ileitis, pseudoappendicitis) are observed
and several fatalities have been reported (3, 16, 26). Due
to the tropism for lymphoid tissues and the spread of the bacterium via
the bloodstream, generalized infections may occur, resulting in
meningitis, endocarditis, and aneurysm (15, 27). As a
result of the host's immune response, Y. enterocolitica may
also induce secondary, postinfectious sequelae such as erythema nodosum
and acute and chronic arthritis (23, 29). An extensive overview of the pathogenic mechanisms of this versatile human pathogen
has recently been described by Goverde (9).
Y. enterocolitica may be separated by serotyping into
approximately 60 serogroups, of which only 11 serogroups are most
frequently associated with human infections (with serogroups O:3, O:8,
O:9, and O:5,27 predominating) (5, 31). One group of
pathogenic strains, comprising serotypes O:4, O:8, O:13a/b, O:18, O:20,
and O:21, was initially mainly isolated in the United States. On the other hand, strains that were the most common causes of yersiniosis in
Europe and Japan, i.e., serotypes O:3 and O:9, were virtually unknown in the United States. Only one pathogenic serotype, i.e., O:5,27, seemed to have a global spread from the very beginning. Since
the early 1980s, however, the distinction between "American" and
"non-American" strains has been fading (5, 9, 31).
Of the six biotypes of Y. enterocolitica, five (biotypes 1B,
2, 3, 4, and 5) are considered pathogenic in humans (4, 9, 18). Strains of these pathogenic biotypes contain markers
associated with virulence, and these are located on the chromosome and
on the pYV virulence plasmid (10, 18).
The sequence of events following ingestion of virulent Y. enterocolitica strains that ultimately leads to multiplication in underlying tissues and entrance into the bloodstream starts with adherence to and invasion of intestinal epithelial cells
(preferentially from the ileum). These first steps of infection require
at least two chromosomal factors, called ail (attachment
invasion locus) and inv (invasion). The
inv gene is present in virulent as well as nonvirulent
strains of Y. enterocolitica, whereas the ail
gene is found only in the pathogenic serotypes of Y. enterocolitica (18, 19). The mode of action of the
ail product, Ail, which is an outer membrane protein, has
not been elucidated so far.
Expression of both plasmid and chromosomal genes is required for
Y. enterocolitica virulence (18, 24). However,
the plasmid has been shown to be difficult to maintain during
laboratory culture, which would increase the chances of obtaining a
false-negative result (8, 13). Consequently, plasmid pYV
is not an ideal DNA target for the detection of pathogenic Y. enterocolitica strains. The chromosomal ail gene,
however, has been shown to be a stable virulence marker limited to only
invasive and, thus, pathogenic strains of Y. enterocolitica
(10). Accordingly, amplification of
ail-specific sequences by diagnostic PCR can be used for the unambiguous identification of invasive Y. enterocolitica
strains. Miller et al. (20) elucidated the nucleotide
sequence of the Y. enterocolitica ail gene in 1990. Besides
the ail primers, we included in the PCR mixture a second
primer set, based on the Y. enterocolitica 16S rRNA gene,
for species identification. In this report, we describe the development
of a rapid and sensitive duplex PCR assay that is specific for the
detection of pathogenic Y. enterocolitica.
Bacterial species and culture conditions.
A total of 215 clinical strains belonging to eight different species of the genus
Yersinia were studied along with 40 non-Yersinia strains (Table 1). The isolates were
selected from the bacterial collection of the National Institute of
Public Health and the Environment (Bilthoven, The Netherlands). Of the
Yersinia strains tested, about 70% were of human origin,
whereas the remaining 30% originated from animals (mainly pigs).
Furthermore, 15 Yersinia type (reference) strains were
selected from the collections of the Institut Pasteur (National
Reference Laboratory and World Health Organization Collaborating Center
for Yersinia, Paris, France) and the University of Louvain
(Brussels, Belgium) (Table 2). Fresh
Yersinia cultures were prepared by overnight incubation on
Cefsulodin-Irgasan-Novobiocin (CIN) agar plates (Oxoid, Basingstoke, United Kingdom) at 30°C. Strains were stored at
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.12.4483-4486.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Detection of Pathogenic Yersinia
enterocolitica by a Rapid and Sensitive Duplex PCR
Assay
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C in peptone broth with 25% (vol/vol) glycerol. The type strains used to test the
specificity of the ail PCR were Listeria
monocytogenes (NCTC 7973), Shigella dysenteriae (NCTC
11867), Campylobacter jejuni (NCTC 11168), Escherichia
coli (CDC P2a), and Salmonella enterica (Institut
Pasteur strain 5338/85).
TABLE 1.
Specificities of the two candidate primer sets for
Y. enterocolitica
TABLE 2.
Type strains belonging to six different
Yersinia species used in the study
DNA isolation.
Genomic DNA was isolated with the QiaAmp
Tissue Kit 250 (Qiagen Inc., Leusden, The Netherlands), according to
the manufacturer's instructions. Purified genomic DNA was diluted to a
concentration of 10 ng/µl in TE buffer (10 mM Tris [pH 8.0], 1 mM
EDTA) and stored at
20°C.
Primer design. Two primer sets (primers A1 and A2 and primers Y1 and Y2) were used in the multiplex PCR assay. Primers A1 (5'-TTA ATG TGT ACG CTG GGA GTG-3') and A2 (5'-GGA GTA TTC ATA TGA AGC GTC-3'), directed against the Y. enterocolitica ail gene, were deduced from sequences in the EMBL database (EMBL accession number M29945). On the basis of this sequence, a PCR product of 425 bp was expected. To specifically amplify the Y. enterocolitica 16S rRNA gene, a second primer set, recently published by Neubauer et al. (21), Y1 (5'-AAT ACC GCA TAA CGT CTT CG-3') and Y2 (5'-CTT CTT CTG CGA GTA ACG TC-3'), was used, resulting in a PCR product of 330 bp.
PCR conditions. Precautions were taken to use sterile reagents and conditions wherever possible. Each 25-µl PCR mixture contained ail-specific primers at a concentration of 160 nM and the Y. enterocolitica 16S rRNA-specific primers at a concentration of 80 nM; dATP, dCTP, dGTP, and dTTP each at a concentration of 200 µM; 0.5 U of SuperTaq Polymerase (Sphaero-Q, Leiden, The Netherlands); 1× PCR buffer (the buffer was supplied at 10×), and 2 µl (i.e., 20 ng) of DNA sample. Amplification was performed in a Primus 96 Plus thermal cycler (MWG-Biotech, Ebersberg, Germany). Cycling conditions started with a denaturation step at 94°C for 5 min, which was followed by 36 subsequent cycles consisting of heat denaturation at 94°C for 45 s, primer annealing at 62°C for 45 s, and extension at 72°C for 45 s. A final extension was performed at 72°C for 7 min to complete the synthesis of all strands. The PCR products were visualized on 1.5% agarose gels stained with ethidium bromide.
| |
RESULTS |
|---|
|
|
|---|
A duplex PCR approach was used for the detection of pathogenic
Y. enterocolitica. The first primer pair (the A1-A2 primer pair) was used to amplify a 0.43-kb fragment of the ail
gene, found exclusively in pathogenic Y. enterocolitica
strains, whereas the second primer pair (the Y1-Y2 primer pair)
amplified a 0.33-kb fragment of the 16S rRNA gene exclusively of the
Y. enterocolitica species (Fig.
1). The entire test could be completed in
4 h, including the DNA extraction step.
|
Theoretical detection limit of PCR.
In order to determine the
sensitivity of the assay, chromosomal DNA from Y. enterocolitica serotype O:3 was isolated with the QiaAmp kit from
overnight cultures of bacteria grown in CIN medium at 30°C. Duplex
PCR was performed by using 100 ng to 1 fg of chromosomal DNA as a
template and the primers described above. A DNA concentration of
5 fg
could be detected (data not shown). On the basis of an average
yersinial genome size of 4,500 kb (25), 5 fg of DNA would
amount to approximately one genome and, hence, one bacterial cell.
Specificity of PCR. The specificity of the duplex PCR assay was examined by isolating genomic DNA from 27 different Y. enterocolitica serogroups, 7 different other Yersinia spp., and 6 different non-Yersinia bacteria pathogenic for humans (Tables 1 and 2). Among the 34 different Yersinia strains, only Y. enterocolitica isolates gave a PCR product of 0.33 kb. Of these, only pathogenic strains (mainly serogroup O:3, O:8, O:9, and O:5,27) gave an additional PCR product of 0.43 kb. No PCR products were observed when non-Yersinia strains were used. The results of the 16S rRNA gene PCR correlated well with the results obtained by Neubauer et al. (21). The retrieval of the PCR product derived from the ail gene only from pathogenic Y. enterocolitica strains indicates the uniqueness of this virulence gene among this yersinial species.
| |
DISCUSSION |
|---|
|
|
|---|
The objective of the present study was to design a sensitive and specific single-reaction PCR assay for the detection of pathogenic Y. enterocolitica strains and to use the assay as a diagnostic tool for the rapid typing of pure yersinial cultures.
The Y1-Y2 primer pair differentiated Y. enterocolitica from a broad spectrum of both Yersinia and non-Yersinia bacteria. The A1-A2 primer pair intrinsically differentiated pathogenic from nonpathogenic Y. enterocolitica bacteria. About 40% of the Y. enterocolitica isolates used in the present study had previously been subjected to tissue culture invasion (TCI) testing by Goverde (9); the results showed a 100% correlation between invasiveness and the serotypes associated with disease. This was in agreement with the results obtained by Miller and colleagues (18, 19) and strongly supports the hypothesis that the TCI+ phenotype corresponds to in vivo pathogenicity.
By our PCR method, in contrast to fluorogenic PCR assays, no post-PCR data analysis is needed. Both primer sets were able to detect Y. enterocolitica in pure culture at a limit of 5 fg of chromosomal DNA, demonstrating that conventional PCR can be as sensitive as fluorogenic PCR (11, 12). Compared to the nonfluorogenic ail PCR of Harnett et al. (11), the detection limit of our PCR seems to be superior (1 pg versus 5 fg of DNA).
The duplex PCR assay provides a more rapid means of accurate identification of pathogenic Y. enterocolitica than present standard methods (i.e., biotyping combined with serotyping), which are time-consuming and laborious. Use of the duplex PCR would significantly reduce the amount of time required to identify pathogenic Y. enterocolitica strains and can be used directly after primary selective culture of this pathogen, with the biotyping and serotyping steps omitted, if necessary.
The (rare) presence of a homologous ail locus has been suggested in strains of Y. pseudotuberculosis (19). Therefore, it cannot be excluded that in our duplex PCR the ail product was found, while no 16S rRNA PCR product appeared. Unfortunately, there are insufficient sequence data for Yersinia spp. other than Y. enterocolitica to prove that they may harbor the ail gene or a version of it (12). None of the 10 Y. pseudotuberculosis strains tested in our study gave a PCR product with the ail-specific primer set.
Some small differences in amino acid composition at the ail locus between the American and non-American serotypes have been discussed (9, 11) and could in theory interfere with primer annealing. Nevertheless, the duplex PCR described in this report is able to unambiguously identify both American and non-American pathogenic Y. enterocolitica strains.
Thus far, only separate 16S rRNA gene and ail gene PCRs have been described for Y. enterocolitica (11, 12, 21, 25). Without the 16S rRNA gene PCR, species confirmation must be obtained by biotyping and serotyping; with our assay it is possible to omit these steps, and therefore, the assay can save time. To our knowledge, this is the first time that a PCR assay that makes use of combined primer sets for both Yersinia species identification and detection of pathogenicity has been described.
In summary, the duplex PCR assay described in this report appears to be a useful tool for the rapid, sensitive, and specific detection of pathogenic Y. enterocolitica. In addition, it can be applied in each laboratory with PCR facilities, even without prior biotyping and serotyping.
| |
ACKNOWLEDGMENTS |
|---|
We thank A. H. A. M. van Hoek and H. J. M. Aarts from the RIKILT Institute, Wageningen, The Netherlands, for providing some of the Yersinia isolates. We also thank F. A. G. Reubsaet and J. F. P. Schellekens from the National Institute of Public Health and the Environment, Bilthoven, The Netherlands, for helpful comments on preparation of the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: National Institute of Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands. Phone: (31) 30 274 2105. Fax: (31) 30 274 4418. E-mail: wim.wannet{at}rivm.nl.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Adesiyun, A. A., and C. Krishnan. 1995. Occurrence of Yersinia enterocolitica O:3, Listeria monocytogenes O:4 and thermophilic Campylobacter spp. in slaughter pigs and carcasses in Trinidad. Food Microbiol. 12:99-107. |
| 2. | Bien, J. P. 1998. Anticipatory guidance and chitterlings. J. Pediatr. 133:712[Medline]. |
| 3. | Bottone, E. J. 1977. Yersinia enterocolitica: a panoramic view of a charismatic micro-organism. Crit. Rev. Microbiol. 5:211-241. |
| 4. | Bottone, E. J. 1997. Yersinia enterocolitica: the charisma continues. Clin. Microbiol. Rev. 10:257-276[Abstract]. |
| 5. | Bottone, E. J. 1999. Yersinia enterocolitica: overview and epidemiologic correlates. Microbes Infect. 1:323-333[CrossRef][Medline]. |
| 6. |
Centers for Disease Control and Prevention.
1998.
Incidence of foodborne ilnesses Foodnet 1997.
Morb. Mortal. Wkly. Rep.
47:782-786[Medline].
|
| 7. |
Centers for Disease Control and Prevention.
1998.
Update: Yersinia enterocolitica bacteraemia and endotoxin shock associated with red blood cell transfusions United States, 1991.
Morb. Mortal. Wkly. Rep.
40:176-178.
|
| 8. | Fenwick, S. G., and A. Murray. 1991. Detection of pathogenic Yersinia enterocolitica by polymerase chain reaction. Lancet 337:497-498. |
| 9. | Goverde, R. L. J. 1999. Yersinia enterocolitica: genes involved in cold-adaptation. Ph.D. thesis. University of Utrecht, Utrecht, The Netherlands. |
| 10. |
Grant, T.,
V. Bennett-Wood, and R. M. Robins-Browne.
1998.
Identification of virulence-associated characteristics in clinical isolates of Yersinia enterocolitica lacking classical virulence markers.
Infect. Immun.
66:1113-1120 |
| 11. | Harnett, N., Y. P. Lin, and C. Krishnan. 1996. Detection of pathogenic Yersinia enterocolitica using the multiplex polymerase chain reaction. Epidemiol. Infect. 117:59-67[Medline]. |
| 12. |
Jourdan, A. D.,
S. C. Johnson, and I. V. Wesley.
2000.
Development of a fluorogenic 5' nuclease PCR assay for detection of the ail gene of pathogenic Yersinia enterocolitica.
Appl. Environ. Microbiol.
66:3750-3755 |
| 13. | Kapperund, G. 1991. Yersinia enterocolitica in food hygiene. Int. J. Food Microbiol. 12:53-66[CrossRef][Medline]. |
| 14. | Klein, H. G., R. Y. Dodd, P. M. Ness, J. A. Fratantoni, and G. J. Nemo. 1997. Current status of microbial contamination of blood components: summary of a conference. Transfusion 37:95-101[CrossRef][Medline]. |
| 15. | La Scola, B., D. Musso, A. Carta, P. Piquet, and J. P. Casalta. 1997. Aortoabdominal aneurysm infected by Yersinia enterocolitica serotype O:9. J. Infect. 35:314-315[CrossRef][Medline]. |
| 16. |
Martin, T.,
G. F. Kasian, and S. Stead.
1982.
Family outbreak of yersiniosis.
J. Clin. Microbiol.
16:622-626 |
| 17. |
McCarthy, M. D., and S. G. Fenwick.
1990.
Experiences with the diagnosis of Yersinia enterocolitica an emerging gastrointestinal pathogen in the Auckland area 1987-1989.
N.Z. J. Med. Lab. Sci.
45:19-22.
|
| 18. |
Miller, V. L., and S. Falkow.
1988.
Evidence for two genetic loci in Yersinia enterocolitica that can promote invasion of epithelial cells.
Infect. Immun.
56:1242-1248 |
| 19. |
Miller, V. L.,
J. J. Farmer,
W. E. Hill, and S. Falkow.
1989.
The ail locus is found uniquely in Yersinia enterocolitica serotypes commonly associated with disease.
Infect. Immun.
57:121-131 |
| 20. |
Miller, V. L.,
J. B. Bliska, and S. Falkow.
1990.
Nucleotide sequence of the Yersinia enterocolitica ail gene and characterization of the Ail protein product.
J. Bacteriol.
172:1062-1069 |
| 21. | Neubauer, H., A. Hensel, S. Aleksic, and H. Meyer. 2000. Identification of Yersinia enterocolitica within the genus Yersinia. Syst. Appl. Microbiol. 23:58-62[Medline]. |
| 22. | Ostroff, S. M. 1995. Yersinia as an emerging infection: epidemiologic aspects of yersiniosis. Contrib. Microbiol. Immunol. 13:5-10[Medline]. |
| 23. | Petrus, M., P. Micheau, M. F. Danjoux, B. Thore, M. Rhabbour, N. Moulie, G. Bildstein, and J. C. Netter. 1997. Succession arthrite purulente puis reactionelle a Yersinia enterocolitica chez un garcon de 8 ans. Sem. Hop. Paris 73:286-288. |
| 24. |
Schiemann, D. A., and J. A. Devenish.
1982.
Relationship of HeLa cell infectivity to biochemical, serological and virulence characteristics of Yersinia enterocolitica.
Infect. Immun.
35:497-506 |
| 25. |
Sen, K.
2000.
Rapid identification of Yersinia enterocolitica in blood by the 5' nuclease PCR assay.
J. Clin. Microbiol.
38:1953-1958 |
| 26. | Staatz, G., G. Alzen, and G. Heimann. 1998. Darminfektion, die haufigste Invaginationsursache im Kindesalter: Ergebnisse einer 10-jahrigen klinischen Studie. Klin. Paediatr. 210:61-64. |
| 27. | Tame, S., D. de Wit, and A. Meek. 1998. Yersinia enterocolitica and mycotic aneurysm. Aust. N.Z. J. Surg. 68:813-814[Medline]. |
| 28. | Tauxe, R. V. 1997. Emerging foodborne diseases: an evolving public health challenge. Emerg. Infect. Dis. 3:425-434[Medline]. |
| 29. | van der Heyden, I. M., P. C. M. Res, B. Wilbrink, A. Leow, F. C. Breedveld, J. Heesemann, and P. P. Tak. 1997. Yersinia enterocolitica: a cause of chronic polyarthritis. Clin. Infect. Dis. 25:831-837[Medline]. |
| 30. |
Wagner, S. J.,
L. I. Friedman, and R. Y. Dodd.
1994.
Transfusion-associated bacterial sepsis.
Clin. Microbiol. Rev.
7:290-302 |
| 31. | Wauters, G., S. Aleksic, J. Charlier, and G. Schulze. 1991. Somatic and flagellar antigens of Yersinia enterocolitica and related species. Contrib. Microbiol. Immunol. 12:239-243[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|